Ms. Nandini Piramal is the Executive Director of Piramal Enterprises and leads the Over-The-Counter (OTC) business of the company. Under Nandini's leadership, the OTC business moved up ranks, from 40 in 2008, to 7 in 2012. She played a pivotal role in Piramal Healthcare's branded generic-medicine business sale to Abbott Laboratories, at a record 30x EBITDA.
She heads the Human Resources function at Piramal Group and the Quality & Risk functions at Piramal Healthcare. She has recently initiated an HR transformation strategy, with renewed focus on service delivery, customer centricity and operational excellence.
In 2014, the World Economic Forum recognised Nandini as a 'Young Global Leader'.
Nandini is passionately involved with Piramal Foundation, the philanthropic arm of the Piramal Group. She directs the implementation strategy across Piramal Foundation Education Leadership programs, Piramal Sarvajal and Piramal Swasthya.
She graduated with BA (Hons.) Politics, Philosophy, and Economics from Oxford University, followed by an MBA from Stanford Graduate School of Business.
Chairman, Piramal Group
Vice Chairperson, Piramal Group
Independent Director, Government of Singapore Investment Corporation Pte Ltd
Chair Professor at the University of Hyderabad
Former Chairman of the Board, Hindustan Unilever Limited
Former Chairman of ICICI Bank Limited
President, Global Research Alliance
Former Vice chairman, Tata Consultancy Services
Director and the former President & CEO of Transunion
Executive Director, Piramal Enterprises
Director, Piramal Glass
Chairman, Piramal Glass Ceylon Plc.
Executive Director, Piramal Group
Non-Executive Director, Piramal Enterprises
Founder, Piramal Realty